Diana Cardona to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Diana Cardona has written about Carcinoma, Hepatocellular.
Connection Strength
0.714
-
Nedrud M, Wolfson T, Allen B, Aslam A, Burke L, Chernyak V, Fowler K, Fraum TJ, Ha HI, Hecht EM, Jaffe T, Kalisz K, Siobhan Kierans A, Ludwig DR, Makkar JS, McGinty K, McInnes M, Mendiratta-Lala M, Oloruntoba O, Ranathunga D, Wildman-Tobriner B, Gamst AC, Cardona DM, Muir A, Bashir M. Predictors of hepatocellular carcinoma in LR-M category lesions, a multi-institutional analysis. Abdom Radiol (NY). 2025 Nov; 50(11):5232-5241.
Score: 0.218
-
Kierans AS, Lafata KJ, Ludwig DR, Burke LMB, Chernyak V, Fowler KJ, Fraum TJ, McGinty KA, McInnes MDF, Mendiratta-Lala M, Cunha GM, Allen BC, Hecht EM, Jaffe TA, Kalisz KR, Ranathunga DS, Wildman-Tobriner B, Cardona DM, Aslam A, Gaur S, Bashir MR. Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas. J Magn Reson Imaging. 2023 Jan; 57(1):308-317.
Score: 0.177
-
Lee TH, Hirshman N, Cardona DM, Berg CL, Fowler KJ, Bashir MR, Ronald J. LR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions. Dig Dis Sci. 2022 Nov; 67(11):5345-5352.
Score: 0.175
-
Shropshire EL, Chaudhry M, Miller CM, Allen BC, Bozdogan E, Cardona DM, King LY, Janas GL, Do RK, Kim CY, Ronald J, Bashir MR. LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy. Radiology. 2019 Jul; 292(1):226-234.
Score: 0.144